Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysis

OBJECTIVES: Response to immune checkpoint inhibitor (ICI) remains limited to a subset of patients and predictive biomarkers of response remains an unmet need, limiting our ability to provide precision medicine. Using real-world data, we aimed to identify potential clinical prognosticators of ICI res...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Qian, Jun, Tomi, Wang, Bo, Patel, Vaibhav G., Mellgard, George, Zhong, Xiaobo, Gogerly-Moragoda, Mahalya, Parikh, Anish B., Leiter, Amanda, Gallagher, Emily J., Alerasool, Parissa, Garcia, Philip, Joshi, Himanshu, MBBS, Galsky, Matthew, Oh, William K., Tsao, Che-Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374856/
https://www.ncbi.nlm.nih.gov/pubmed/35960456
http://dx.doi.org/10.1007/s12672-022-00538-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374856/
https://www.ncbi.nlm.nih.gov/pubmed/35960456
http://dx.doi.org/10.1007/s12672-022-00538-6

Ejemplares similares